Search research articles
Contact Us
Filters
Showing results (411-420 of 485) with videos related to
Page
of 49
Sort By:
International Journal of Environmental Research and Public Health
|
May 4, 2026
Increased Density of Mobile Health Unit Encounters Among Primary Care Health Professional Shortage Areas
Phillip D Levy, Michael J Twiner, Bethany Foster, et al.
European Heart Journal
|
August 14, 2018
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
James Brian Byrd, David E Newby, Julie A Anderson, et al.
Respiratory Medicine
|
September 27, 2017
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
Courtney Crim, Peter M A Calverley, Julie A Anderson, et al.
Circulation
|
April 15, 2024
The Urban Environment and Cardiometabolic Health
Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, et al.
Circulation Research
|
January 22, 2019
Extreme Levels of Air Pollution Associated With Changes in Biomarkers of Atherosclerotic Plaque Vulnerability and Thrombogenicity in Healthy Adults
Hongbing Xu, Tong Wang, Shengcong Liu, et al.
ERJ Open Research
|
March 1, 2019
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
Jørgen Vestbo, Mark Dransfield, Julie A Anderson, et al.
The New England Journal of Medicine
|
December 14, 2016
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A Ference, Jennifer G Robinson, Robert D Brook, et al.
Journal of the American Society of Hypertension : JASH
|
October 17, 2017
Extreme levels of ambient air pollution adversely impact cardiac and central aortic hemodynamics: the AIRCMD-China study
Shuo Liu, Robert D Brook, Wei Huang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 25, 2017
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk
Peter M A Calverley, Julie A Anderson, Robert D Brook, et al.
Heart (British Cardiac Society)
|
April 19, 2017
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
Robert D Brook, Julie A Anderson, Peter Ma Calverley, et al.
Page
of 49
Search research articles
Search
Showing results (411-420 of 485) with videos related to
Sort By:
Page
of 49
International Journal of Environmental Research and Public Health
|
May 4, 2026
Increased Density of Mobile Health Unit Encounters Among Primary Care Health Professional Shortage Areas
Phillip D Levy, Michael J Twiner, Bethany Foster, et al.
European Heart Journal
|
August 14, 2018
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
James Brian Byrd, David E Newby, Julie A Anderson, et al.
Respiratory Medicine
|
September 27, 2017
Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial
Courtney Crim, Peter M A Calverley, Julie A Anderson, et al.
Circulation
|
April 15, 2024
The Urban Environment and Cardiometabolic Health
Sanjay Rajagopalan, Armando Vergara-Martel, Jeffrey Zhong, et al.
Circulation Research
|
January 22, 2019
Extreme Levels of Air Pollution Associated With Changes in Biomarkers of Atherosclerotic Plaque Vulnerability and Thrombogenicity in Healthy Adults
Hongbing Xu, Tong Wang, Shengcong Liu, et al.
ERJ Open Research
|
March 1, 2019
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
Jørgen Vestbo, Mark Dransfield, Julie A Anderson, et al.
The New England Journal of Medicine
|
December 14, 2016
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Brian A Ference, Jennifer G Robinson, Robert D Brook, et al.
Journal of the American Society of Hypertension : JASH
|
October 17, 2017
Extreme levels of ambient air pollution adversely impact cardiac and central aortic hemodynamics: the AIRCMD-China study
Shuo Liu, Robert D Brook, Wei Huang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 25, 2017
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk
Peter M A Calverley, Julie A Anderson, Robert D Brook, et al.
Heart (British Cardiac Society)
|
April 19, 2017
Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
Robert D Brook, Julie A Anderson, Peter Ma Calverley, et al.
Page
of 49